Tech Company Financing Transactions
LumiThera Funding Round
On 11/1/2017, LumiThera landed $5.5 million in Series B financing from WaterStone Capital and RPR Venture.
Transaction Overview
Company Name
Announced On
11/1/2017
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series B
Investors
WaterStone Capital (Lead Investor) (Yigang Yang)
Proceeds Purpose
The proceeds of the financing are being used to support obtaining regulatory clearances of its device in select countries outside the USA including the CE Mark in Europe and to fund additional clinical and commercial activities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
19578 10th Ave. NE 200
Poulsbo, WA 98370
USA
Poulsbo, WA 98370
USA
Phone
Website
Email Address
Not Recorded
Overview
LumiThera's founders and advisors are comprised of experienced scientists, physicians, and engineers in photobiomodulation (PBM) fields. They recognize that multiple, unmet clinical needs exist for non-invasive approaches to debilitating acute and chronic ocular diseases and disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clark Tedford
VP - Marketing
Tracy Puckett
VP - Operations
Cindy Croissant
VP - Product Management
Scott Bradley
VP - Regulatory Affairs
Robert Bard
VP - Sales
Duane Morrison
Browse more venture capital transactions:
Prev: 11/1/2017: Reaction Commerce venture capital transaction
Next: 11/1/2017: Eden Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs